- Home
- MRUS vs M Comparison
MRUS vs M Comparison
Compare MRUS & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- M
- Stock Information
- Founded
- MRUS 2003
- M 1830
- Country
- MRUS Netherlands
- M United States
- Employees
- MRUS N/A
- M N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- M Department/Specialty Retail Stores
- Sector
- MRUS Health Care
- M Consumer Discretionary
- Exchange
- MRUS Nasdaq
- M Nasdaq
- Market Cap
- MRUS 4.1B
- M 3.5B
- IPO Year
- MRUS 2016
- M N/A
- Fundamental
- Price
- MRUS $67.47
- M $17.35
- Analyst Decision
- MRUS Strong Buy
- M Hold
- Analyst Count
- MRUS 13
- M 10
- Target Price
- MRUS $90.92
- M $15.06
- AVG Volume (30 Days)
- MRUS 550.9K
- M 10.3M
- Earning Date
- MRUS 10-30-2025
- M 09-03-2025
- Dividend Yield
- MRUS N/A
- M 4.22%
- EPS Growth
- MRUS N/A
- M 169.50
- EPS
- MRUS N/A
- M 1.77
- Revenue
- MRUS $56,228,000.00
- M $22,701,000,000.00
- Revenue This Year
- MRUS $57.42
- M N/A
- Revenue Next Year
- MRUS $0.23
- M N/A
- P/E Ratio
- MRUS N/A
- M $9.79
- Revenue Growth
- MRUS 59.77
- M N/A
- 52 Week Low
- MRUS $33.19
- M $9.76
- 52 Week High
- MRUS $69.20
- M $18.13
- Technical
- Relative Strength Index (RSI)
- MRUS 58.81
- M 81.17
- Support Level
- MRUS $62.80
- M $13.09
- Resistance Level
- MRUS $67.84
- M $13.80
- Average True Range (ATR)
- MRUS 2.39
- M 0.54
- MACD
- MRUS -0.22
- M 0.44
- Stochastic Oscillator
- MRUS 73.67
- M 95.61
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.